Is EQUR or JEPQ a better dividend investment in 2026?

EQUR currently yields 1000000.00% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: EQUR offers higher current income.

What is the dividend yield difference between EQUR and JEPQ?

EQUR has a forward dividend yield of 1000000.00% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 999988.90 percentage points.

Home › Compare › EQUR vs JEPQ

EQUR vs JEPQ: Dividend Comparison 2026

EQUR yields 1000000.00% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EQUR wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EQUR

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full EQUR calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — EQUR vs JEPQ

📍 EQUR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EQUR	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EQUR + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EQUR pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EQUR

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, EQUR beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EQUR + JEPQ for your $10,000?

EQUR: 50%JEPQ: 50%

100% JEPQ50/50100% EQUR

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EQUR buys

JEPQ buys

No recent congressional trades found for EQUR or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEQURJEPQ

Forward yield	1000000.00% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.7683925249533696e+36M	$44.8K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$2,152.59
Total dividends collected	$4.7683311610149396e+36M	$16.3K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: EQUR vs JEPQ ($10,000, DRIP)

Year	EQUR Portfolio	EQUR Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,930	$1,110.39	+$100.00M → EQUR
2	$934,786,450,701	$934,679,439,252.34	$14,133	$1,224.34	+$934786.44M → EQUR
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$16,632	$1,340.46	+$8165787108.56M → EQUR
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$19,454	$1,457.97	+$66665884190957.63M → EQUR
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$22,626	$1,576.08	+$508662171058048128.00M → EQUR
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$26,175	$1,694.09	+$3.62723524842849e+21M → EQUR
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$30,133	$1,811.32	+$2.417368115915061e+25M → EQUR
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$34,531	$1,927.17	+$1.5056740286145463e+29M → EQUR
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$39,403	$2,041.08	+$8.764771002818475e+32M → EQUR
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$44,787	$2,152.59	+$4.7683925249533696e+36M → EQUR

EQUR vs JEPQ: Complete Analysis 2026

EQUR — Stock

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.

Full EQUR Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this EQUR vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EQUR vs SCHD EQUR vs JEPI EQUR vs O EQUR vs KO EQUR vs MAIN EQUR vs XYLD EQUR vs QYLD EQUR vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.